pharmaceutical-investing Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial
pharmaceutical-investing Reata Pharmaceuticals Announces First Quarter 2018 Financial Results and an Update on Development Programs
pharmaceutical-investing Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis
pharmaceutical-investing Selecta Biosciences Announces Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
SweetWater 420 Fest Unveils Powerhouse 2026 Lineup: Umphrey's McGee, Thievery Corporation & Chromeo to Headline
CoTec Québec Onboards BBA To Deliver Feasibility Study, Commences Environmental Baseline Studies and Appoints Corem To Complete Metallurgical Testing Program On Lac Jeannine Iron Tailings Project
Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development
